retatrutide nash Phase 2 trial results demonstrate benefits of in obesity, type 2 diabetes, Retatrutide: Evidence, Safety & Options

It was the highest-selling drug by revenue in the country last year

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily used to manage type 2 diabetes mellitus and, in some formulations, obesity

But the fat-burning signal from endogenous GH release is indirect and relatively weak compared to the direct triple-receptor activation that Retatrutide provides

Nice-to-have supplies Cotton balls or gauze pads

Ask your GP or pharmacist

We want to ensure that you receive the best possible care during your treatment and that you receive the necessary support in the event of any undesirable side effects